Skip to main content
. 2021 Oct 27;11:714551. doi: 10.3389/fonc.2021.714551

Table 4.

Maximal toxicity per patient.

Grade I-II Grade III Grade IV
Overall toxicities [n (%)] 21 (35) 30 (50)
Non hematologic toxicities [n (%)] 14 (23) 15 (25)
Cutaneous 12 (20) 7 (12) 0
Neuropathy 3 (5) 2 (3) 0
Electrolytes disorders 3 (5) 5 (8) 2 (3)
Infusion reaction 3(5) 1 (2) 0
Nausea 5 (8) 0 0
Diarrhea 4 (7) 1 (2) 0
Hematologic toxicities [n (%)] 17 (28) 21 (35)
Neutropenia 30 (50) 8 (13) 7 (12)
Anemia 26 (43) 7 (12) 0
Thrombopenia 7 (12) 1 (2) 0
Toxicity-related data [n (%)]
Blood transfusion 18 (30)
EPO (secondary prophylaxis) 9 (15)
G-CSF (primary prophylaxis) 4 (7)
G-CSF required (secondary prophylaxis) 30 (50)
Febrile neutropenia 6 (10)
Hospitalisation due to infection 16 (27)
Hospitalisation 26 (43)
Deaths in association with AEs 4 (6,6)